11-Nor-9-carboxy-delta-9-tetrahydrocannabinol-D3 2TMS
Compound with spectra: 2 MS (GC)
| SpectraBase Compound ID | FjOA05kHFG6 |
|---|---|
| InChI | InChI=1S/C27H44O4Si2/c1-10-11-12-13-19-16-23-25(24(17-19)30-32(4,5)6)21-18-20(26(28)31-33(7,8)9)14-15-22(21)27(2,3)29-23/h16-18,21-22H,10-15H2,1-9H3/i2D3 |
| InChIKey | RLALMBCUXILXIS-BMSJAHLVSA-N |
| Mol Weight | 491.8 g/mol |
| Molecular Formula | C27H41D3O4Si2 |
| Exact Mass | 491.296643 g/mol |
| Copyright | Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | DigiLab GmbH (C) 2024 |
| Technique | GC/MS |
| Copyright | Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | DigiLab GmbH (C) 2024 |
| Technique | GC/MS |
- trimethylsilyl 6-(2H3)methyl-6-methyl-3-pentyl-1-((trimethylsilyl)oxy)-6a,7,8,10a-tetrahydro-6H-\rbenzo[c]chromene-9-carboxylate
[(8-([Dimethyl(phenyl)silyl]oxy)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-yl)oxy](dimethyl)phenylsilane
3-(4-CHLOROPHENYL)-2-[(4-CHLOROPHENYL)-AMINO]-5-(ETHOXYCARBONYL)-7-METHYLPYRIDO-[2,3,4-DE]-QUINAZOLINE
Ethyl (1RS,2SR,3RS,4RS,5SR)-2-hydroxy-4-methoxy-5-methyl-3-[(2''-trimethylsilyl)ethoxymethoxy]-2-[2'-(trimethylsilyl)-3'-furyl]-cyclohexane-1-carboxylate
UGONIN-L;4''A,5'',6'',7'',8'',8''A-HEXAHYDRO-3',4'-DIHYDROXY-7-METHOXY-5'',5'',8''A-TRIMETHYL-4H-CHROMENO-[2'',3'':5,6]-FLAVONE
6-ACETYL-ANTIRRINOSIDE
10-EPI-UVEOSIDE
TETRAACETYLCAMPSISIDE
2-Butenoic acid, 2-methyl-, 3a,4,5,6,8,8a-hexahydro-3,5',6-trimethyl-2,3'-dioxospiro[7H-cyclohepta[b]furan-7,2'(3'H)-furan]-8-yl ester, [3R-[3.alpha.,3a.beta.,6.alpha.,7.alpha.,8.beta.(Z),8a.beta.]]-
21-Hydroxypregn-4-ene-3,11,20-trione, methyl carbonate
O-Methylpanurensine
This compound is available in the following databases:
Mass Spectra of Designer Drugs 2024
Author: Peter Rösner
This library enables fast and reliable identification of the latest illegal designer drugs. It is updated annually. Learn more.